COVID-19
Conditions
Interventions
Study group (Children recovering form COVID-19 infection, sedated with dexmedetomidine):N/A
Control group (Children sedated with dexmedetomidine before COVID-19 pandemic):N/A
Sponsors
Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
0.1 Years to 3 Years
Inclusion criteria
Inclusion criteria: Children sedated with dexmedetomidine for procedural sedation in sedation clinic in Shanghai Children's Medical Center
Exclusion criteria
Exclusion criteria: (1) Newborns, or over 3 years old (2) On the day of sedation, the patient had respiratory tract infection or fever (3) Overweight/obese (4) Sleep apnea syndrome/snoring (5) History of cardiac conduction system disease (6) Cyanotic congenital heart disease without treatment (7) Recent history of use of beta-blockers, calcium channel blockers, or digoxin (8) Allergic to dexmedetomidine (9) History of any other systemic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate;Blood pressure;Pulse oxygen saturation;Onset time;Wake-up time; | — |
Countries
People's Republic of China
Contacts
Public ContactBo Li
Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University School of Medicine
Outcome results
None listed